76 related articles for article (PubMed ID: 17869221)
1. Analysis of p53-RNA interactions in cultured human cells.
Riley KJ; James Maher L
Biochem Biophys Res Commun; 2007 Nov; 363(2):381-7. PubMed ID: 17869221
[TBL] [Abstract][Full Text] [Related]
2. Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.
Riley KJ; Cassiday LA; Kumar A; Maher LJ
RNA; 2006 Apr; 12(4):620-30. PubMed ID: 16581806
[TBL] [Abstract][Full Text] [Related]
3. p53 RNA interactions: new clues in an old mystery.
Riley KJ; Maher LJ
RNA; 2007 Nov; 13(11):1825-33. PubMed ID: 17804642
[TBL] [Abstract][Full Text] [Related]
4. An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection.
Rosenke K; Samuel MA; McDowell ET; Toerne MA; Fortunato EA
Virology; 2006 Apr; 348(1):19-34. PubMed ID: 16455125
[TBL] [Abstract][Full Text] [Related]
5. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
[TBL] [Abstract][Full Text] [Related]
6. RNA-p53 interactions in vitro.
Riley KJ; Ramirez-Alvarado M; Maher LJ
Biochemistry; 2007 Mar; 46(9):2480-7. PubMed ID: 17288451
[TBL] [Abstract][Full Text] [Related]
7. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
8. High content screening biosensor assay to identify disruptors of p53-hDM2 protein-protein interactions.
Hua Y; Strock CJ; Johnston PA
Methods Mol Biol; 2015; 1278():555-65. PubMed ID: 25859976
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
11. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
13. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
14. The cysteine residues of the hepatitis B virus onco-protein HBx are not required for its interaction with RNA or with human p53.
de Moura PR; Rui E; de Almeida Gonçalves K; Kobarg J
Virus Res; 2005 Mar; 108(1-2):121-31. PubMed ID: 15681062
[TBL] [Abstract][Full Text] [Related]
15. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.
Watts GS; Oshiro MM; Junk DJ; Wozniak RJ; Watterson S; Domann FE; Futscher BW
Neoplasia; 2004; 6(3):187-94. PubMed ID: 15153330
[TBL] [Abstract][Full Text] [Related]
16. eRNAs are required for p53-dependent enhancer activity and gene transcription.
Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
[TBL] [Abstract][Full Text] [Related]
17. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
Lilling G; Elena N; Sidi Y; Bakhanashvili M
Oncogene; 2003 Jan; 22(2):233-45. PubMed ID: 12527892
[TBL] [Abstract][Full Text] [Related]
18. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53.
Rho SB; Lee JH; Park MS; Byun HJ; Kang S; Seo SS; Kim JY; Park SY
FEBS Lett; 2011 Jan; 585(1):29-35. PubMed ID: 21081126
[TBL] [Abstract][Full Text] [Related]
20. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.
Dell'Orso S; Fontemaggi G; Stambolsky P; Goeman F; Voellenkle C; Levrero M; Strano S; Rotter V; Oren M; Blandino G
OMICS; 2011 May; 15(5):305-12. PubMed ID: 21332394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
